The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Open accessAbstract
OBJECTIVE: To investigate whether placebo effects can experimentally be separated into the response to three components-assessment and observation, a therapeutic ritual (placebo treatment), and a supportive patient-practitioner relationship-and then progressively combined to produce incremental clinical improvement in patients with irritable bowel syndrome. To assess the relative magnitude of these components. DESIGN: A six week single blind three arm randomised controlled trial. SETTING: Academic medical centre. PARTICIPANTS: 262 adults (76% women), mean (SD) age 39 (14), diagnosed by Rome II criteria for and with a score of > or =150 on the symptom severity scale. INTERVENTIONS: For three weeks either waiting list (observation), placebo acupuncture alone ("limited"), or placebo acupuncture with a patient-practitioner relationship augmented by warmth, attention, and confidence ("augmented"). At three weeks, half of the patients were randomly assigned to continue in their originally assigned group for an additional three weeks. MAIN OUTCOME MEASURES: Global improvement scale (range 1-7), adequate relief of symptoms, symptom severity score, and quality of life. RESULTS: At three weeks, scores on the global improvement scale were 3.8 (SD 1.0) v 4.3 (SD 1.4) v 5.0 (SD 1.3) for waiting list versus "limited" versus "augmented," respectively (P<0.001 for trend). The proportion of patients reporting adequate relief showed a similar pattern: 28% on waiting list, 44% in limited group, and 62% in augmented group (P<0.001 for trend). The same trend in response existed in symptom severity score (30 (63) v 42 (67) v 82 (89), P<0.001) and quality of life (3.6 (8.1) v 4.1 (9.4) v 9.3 (14.0), P<0.001). All pairwise comparisons between augmented and limited patient-practitioner relationship were significant: global improvement scale (P<0.001), adequate relief of symptoms (P<0.001), symptom severity score (P=0.007), quality of life (P=0.01). Results were similar at six week follow-up. CONCLUSION: Factors contributing to the placebo effect can be progressively combined in a manner resembling a graded dose escalation of component parts. Non-specific effects can produce statistically and clinically significant outcomes and the patient-practitioner relationship is the most robust component. TRIAL REGISTRATION: Clinical Trials NCT00065403.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the four dependent variables (global improvement, adequate relief, symptom severity, and quality of life), the two sham acupuncture conditions were superior to treatment as usual.However, the augmented relationship condition was superior to the limited interaction condition, particularly for quality of life.”
From How important are the common factors in psychotherapy? An update (2015) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Self-citationFRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708
Neurobiological Mechanisms of the Placebo Effect
Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J.-K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3458-05.2005 · Cited by 812
Treatment fidelity in outcome studies
Moncher, F. J., & Prinz, R. J. (1991) · Clinical Psychology Review · doi:10.1016/0272-7358(91)90103-2 · Cited by 797 · cited 1×
“The practitioners in this study consisted of four licensed acupuncturists, all of whom had participated in previous randomised placebo controlled trials on acupuncture. The practitioners’ training followed methods described in earlier studies of structured patient-physician interactions.”
MethodKaptchuk, T. J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00011 · Cited by 619
Self-citationDrossman, D. A., Toner, B. B., Whitehead, W. E., Diamant, N. E., Dalton, C. B., Duncan, S., Emmott, S., Proffitt, V., Akman, D., Frusciante, K., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00669-3 · Cited by 614
Self-citationCamilleri, M., Northcutt, A. R., Kong, S., Dukes, G. E., McSorley, D., & Mangel, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02033-x · Cited by 551
Sham device v inert pill: randomised controlled trial of two placebo treatments
Kaptchuk, T. J., Stason, W. B., Davis, R. B., Legedza, A., Schnyer, R. N., Kerr, C. E., Stone, D. A., Nam, B. H., Kirsch, I., & Goldman, R. H. (2006) · BMJ · doi:10.1136/bmj.38726.603310.55 · Cited by 535
Self-citationAdjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial
Lang, E. V., Benotsch, E. G., Fick, L. J., Lutgendorf, S., Berbaum, M. L., Berbaum, K. S., Logan, H., & Spiegel, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02162-0 · Cited by 513
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire
Drossman, D. A., Patrick, D. L., Whitehead, W. E., Toner, B. B., Diamant, N. E., Hu, Y., Jia, H., & Bangdiwala, S. I. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01941.x · Cited by 424
Self-citationThe Irritable Bowel Syndrome: Long-Term Prognosis and the Physician-Patient Interaction
Owens, D. M., Nelson, D. K., & Talley, N. J. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-2-199501150-00005 · Cited by 349
‘Powerful Placebo: The Dark Side of the Randomised Controlled Trial’
Kaptchuk, T. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10111-8 · Cited by 339
Self-citationKleinhenz, J., Streitberger, K., Windeler, J., Gübacher, A., Mavridis, G., & Martin, E. (1999) · Pain · doi:10.1016/s0304-3959(99)00107-4 · Cited by 295
Survey of the AGA Membership Relating to Patients With Functional Gastrointestinal Disorders
Mitchell, C. M., & Drossman, D. A. (1987) · Gastroenterology · doi:10.1016/s0016-5085(87)91099-7 · Cited by 292
Self-citationNovick, J. S., Miner, P. B., Krause, R. A., Glebas, K., Bliesath, H., Ligozio, G., Rüegg, P. C., & Lefkowitz, M. P. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01372.x · Cited by 288
The placebo effect in irritable bowel syndrome trials: a meta‐analysis1
Patel, S. M., Stason, W. B., Legedza, A., Ock, S. M., Kaptchuk, T. J., Conboy, L., Canenguez, K., Park, J. K., Kelly, E., Jacobson, E., et al. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00650.x · Cited by 285
Self-citationPredictive Value of The Rome Criteria for Diagnosing The Irritable Bowel Syndrome
Vanner, S., Depew, W. T., Paterson, W. G., DaCosta, L. R., Groll, A., Simon, J. B., & Djurfeldt, M. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01437.x · Cited by 262
The power of context: reconceptualizing the placebo effect
Miller, F. G., & Kaptchuk, T. J. (2008) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2008.070466 · Cited by 228
Self-citationFunctional bowel disorders and functional abdominal pain
Thompson, W., Irvine, E., Drossman, D., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/x3mq-ct28 · Cited by 204
Self-citationLembo, T., Wright, R. A., Bagby, B., Decker, C., Gordon, S., Jhingran, P. M., & Carter, E. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04128.x · Cited by 191
The economic impact of irritable bowel syndrome
Inadomi, J. M., Fennerty, M. B., & Bjorkman, D. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.t01-1-01736.x · Cited by 190
What are the main methodological problems in the estimation of placebo effects?
Hróbjartsson, A. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00496-6 · Cited by 171
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia
Hammer, J., Eslick, G. D., Howell, S. C., Altiparmak, E., & Talley, N. J. (2004) · Gut · doi:10.1136/gut.2003.021857 · Cited by 170
Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology
Pacheco‐López, G., Engler, H., Niemi, M., & Schedlowski, M. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.05.003 · Cited by 165
Adequate Relief as an Endpoint in Clinical Trials in Irritable Bowel Syndrome
Mangel, A. W., Hahn, Heath, A., Northcutt, A., Kong, S., Dukes, G., & McSorley, D. (1998) · Journal of International Medical Research · doi:10.1177/030006059802600203 · Cited by 144
Harnessing placebo effects in health care
de Saintonge, D. M. C., & Herxheimer, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91647-0 · Cited by 140
Keefer, L., & Blanchard, E. B. (2001) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(00)00078-4 · Cited by 104
Primary Endpoints for Irritable Bowel Syndrome Trials: A Review of Performance of Endpoints
Camilleri, M., Mangel, A. W., Fehnel, S. E., Drossman, D. A., Mayer, E. A., & Talley, N. J. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.03.004 · Cited by 91
Self-citationGordon, S., Ameen, V. Z., Bagby, B., Shahan, B., Jhingran, P. M., & Carter, E. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1024159226274 · Cited by 84
A Signal Detection Theory Analysis of the Placebo Effect
Allan, L. G., & Siegel, S. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702238054 · Cited by 69
A course of instruction for women with irritable bowel syndrome
Bengtsson, M., Ulander, K., Börgdal, E. B., Christensson, A.-C., & Ohlsson, B. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2005.06.015 · Cited by 37
Personal view: adequate relief as a primary endpoint in irritable bowel syndrome
Mangel, A. W. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02839.x · Cited by 19
Systematic review: the economic impact of irritable bowel syndrome
Jorkman, D. B. (2003) · Cited by 15
Adequate relief as an endpoint in clinical trials in irritable bowel syndrome
Mangel, A. W., Hahn, B., Heath, A., Northcutt, A. R., Kong, S., Dukes, G. E., & McSorley, D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)83255-1 · Cited by 11
Anemic Halos Around Telangiectasias
Brandt, L. J. (1987) · Gastroenterology · doi:10.1016/s0016-5085(87)91096-1 · Cited by 9
Research works printed but not linked: 3
- [7]7. PatelSM,StasonWB,LegedzaA,OckSM,KaptchukTJ,ConboyL,etal. The placebo effect irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 2005;17:332-40.
- [15]15. Chaput de Saintonge M, Herxheimer A. Harnessing the placebo effect in healthcare. Lancet 1994;344:995-8.
- [17]17. Drossman DA, Drossman D, Toner BB, Whitehead WE, Diamant NE, Dalton CB, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003;125:19-31.
Cited by
Sorted by citations
Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R. L., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,271
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
Simon, L. S. (2012) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2012.678473 · Cited by 2,200
How important are the common factors in psychotherapy? An update
Wampold, B. E. (2015) · World Psychiatry · doi:10.1002/wps.20238 · Cited by 1,728
Biological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F. G., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,309
Self-citationPlacebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015591 · Cited by 900
Self-citation
Metadata
- Authors
- Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., Park, M., Rivers, A. L., McManus, C., Kokkotou, E., Drossman, D. A., Goldman, P., & Lembo, A. J.
- Affiliations
- Harvard University (US)
- Endicott College (US)
- Beth Israel Deaconess Medical Center (US)
- University of Hull (GB)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Kaptchuk, Ted J
- ORCID
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2008-04-03
- Volume
- 336
- Issue
- 7651
- Pages
- 999-1003
- ISSN
- 1756-1833 (ISSN-L)
- 0959-8138
- PMC
- PMC2364862
- OpenAlex
- W2038810061
- Cited by
- 1,196
- References
- 35
- Citations by year
- 2026: 32 · 2025: 48 · 2024: 49 · 2023: 53 · 2022: 56 · 2021: 78 · 2020: 70 · 2019: 78 · 2018: 75 · 2017: 80 · 2016: 72 · 2015: 66 · 2014: 77 · 2013: 76 · 2012: 60
- FWCI
- 38.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- BMJ (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Beth Israel Deaconess Medical Center
- Harvard University
- National Institutes of Health (5r21at002564-02)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Complementary and Alternative Medicine
- National Center for Research Resources (RR 01032, M01RR001032)
- Office of Behavioral and Social Sciences Research
- National Center for Complementary and Integrative Health (R01AT004662, R21AT002860, 1R21 AT002564, K24AT004095, R01AT001414)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Complementary and alternative medicine › Acupuncture Treatment Research Studies
- Keywords
- placebo effect, irritable bowel syndrome, sham acupuncture, patient-practitioner relationship, healing rituals, non-specific effects, symptom severity, quality of life, symptom relief, placebo-controlled trial design
- MeSH terms
- Adult, Female, Humans, Male, Waiting Lists, Acupuncture Therapy, Placebo Effect, Single-Blind Method, Treatment Outcome, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
